Genesis Healthcare Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 10/03/2023

Stock Rating
10
Price Target
$25.00
Consensus
Outperform
Upside
42.61%
Analysts
1
Stock Rating
10
Upside
42.61%
Analysts
1
Price Target
$25.00

Genesis Healthcare Inc Stock Forecast and Price Target

If the average price target of $25.00 set by distinguished experts for Genesis Healthcare Inc over the past few weeks is reached this year, there would be a potential upside of approximately 42.61% from the last closing price in October, 2023. This potential increase is based on a high estimate of $29.00 and a low estimate of $24.00. Even if not interested in GEN stock, you may want to be aware of its competitors.

$25.00

42.61% Upside

Outperform
Outperform

Genesis Healthcare Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Genesis Healthcare Inc's Price has grown from $24.25 to $33.55 – a 38.36% increase. For the next year, 3 analysts project Genesis Healthcare Inc's Fair Value to drop by 6.36%, reaching $31.42. Over the next seven years, the forecast is for Fair Value to grow by 18.34%.

2024 Fair Value Forecast
$31.42
2025 Fair Value Forecast
$29.74
2026 Fair Value Forecast
$34.47
2027 Fair Value Forecast
$35.53
2028 Fair Value Forecast
$48.50
2029 Fair Value Forecast
$41.47
2030 Fair Value Forecast
$39.70
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
MSFT Stock Forecast Microsoft Corp Outperform 16
$321.81 $388.71 -12.99%
CRM Stock Forecast salesforce.com, inc. Outperform 14
$203.71 $256.11 -9.18%
INTU Stock Forecast Intuit Inc Outperform 9
$517.80 $554.52 -8.46%
NOW Stock Forecast ServiceNow Inc Buy 11
$555.23 $521.22 -8.15%
ATVI Stock Forecast Activision Blizzard Inc Hold 17
$93.94 $91.45 1.13%

Genesis Healthcare Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Revenue has grown from $2.46B to $3.34B – a 35.91% increase. For the next year, 4 analysts project Genesis Healthcare Inc's Revenue to drop by 5.12%, reaching $3.17B. Over the next seven years, the forecast is for Revenue to grow by 16.03%.

2024 Rev Forecast
$3.17B
2025 Rev Forecast
$3.12B
2026 Rev Forecast
$3.37B
2027 Rev Forecast
$3.44B
2028 Rev Forecast
$4.59B
2029 Rev Forecast
$4.06B
2030 Rev Forecast
$3.87B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SNPS Stock Forecast Synopsys Buy 16
$463.97 $485.23 -9.48%
CDNS Stock Forecast Cadence Design Systems Inc Outperform 16
$236.49 $191.63 -15.43%
EA Stock Forecast Electronic Arts Inc Outperform 16
$120.15 $144.50 24.84%

Genesis Healthcare Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Dividend per Share has grown by 66.67%, rising from $0.30 to $0.50. According to 1 prominent analysts, Genesis Healthcare Inc's Dividend per Share will fall by 0.00% in the next year, reaching $0.50. Over the next seven years, experts predict that Genesis Healthcare Inc's Dividend per Share will grow at a rate of 1.37%.

2024 DPS Forecast
$0.50
2025 DPS Forecast
$0.50
2026 DPS Forecast
$0.52
2027 DPS Forecast
$0.52
2028 DPS Forecast
$0.50
2029 DPS Forecast
$0.50
2030 DPS Forecast
$0.51
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ANSS Stock Forecast ANSYS Inc Outperform 16
$297.48 $250.24 -15.46%
TTWO Stock Forecast Take-Two Interactive Software ... Outperform 12
$139.00 $136.07 -5.04%
NUAN Stock Forecast Nuance Communications - 12
$55.99 $57.00 -62.49%

Genesis Healthcare Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Free Cash Flow has grown, rising from $1.29B to $851.00T – a growth of 66071328.11%. According to 1 major analysts, Genesis Healthcare Inc's Free Cash Flow will fall by 100.00% in the next year, reaching $1.34B. Professionals believe that By 2030, Genesis Healthcare Inc's Free Cash Flow will fall to $1.33B– a 100.00% decrease from its current value.

2024 FCF Forecast
$1.34B
2025 FCF Forecast
$1.15B
2026 FCF Forecast
$1.21B
2027 FCF Forecast
$1.25B
2028 FCF Forecast
$1.50B
2029 FCF Forecast
$1.38B
2030 FCF Forecast
$1.33B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SPLK Stock Forecast Splunk Outperform 7
$96.69 $123.41 12.73%
SSNC Stock Forecast SS&C Technologies Holdings Inc Outperform 18
$55.51 $65.55 17.10%
PTC Stock Forecast PTC Outperform 15
$140.84 $142.86 2.95%

Genesis Healthcare Inc Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Genesis Healthcare Inc's Net Income has grown by 4251.61%, rising from $31.00M to $1.35B. In the following year, 3 experts forecast Genesis Healthcare Inc's Net Income will decrease by 11.20%, to $1.20B. Over the next seven years, experts predict that Genesis Healthcare Inc's Net Income will grow at a rate of 17.27%.

2024 NI Forecast
$1.20B
2025 NI Forecast
$1.20B
2026 NI Forecast
$1.30B
2027 NI Forecast
$1.32B
2028 NI Forecast
$1.96B
2029 NI Forecast
$1.68B
2030 NI Forecast
$1.58B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
CTXS Stock Forecast Citrix Systems - 13
$103.90 $105.86 -1.59%
NasdaqGS:AZPN Stock Forecast AspenTech - 16
$166.30 $152.67 49.75%
PFPT Stock Forecast Proofpoint - 10
$175.90 $172.31 2.03%

Genesis Healthcare Inc EBITDA Forecast for 2023 - 2025 - 2030

Genesis Healthcare Inc's EBITDA has grown In the last three years, rising from $596.00M to $1.60B – a growth of 168.96%. In the next year, analysts believe that EBITDA will reach $1.65B – an increase of 3.09%. For the next seven years, experts predict that Genesis Healthcare Inc's EBITDA will grow at a rate of 54.24%.

2024 EBITDA Forecast
$1.65B
2025 EBITDA Forecast
$1.67B
2026 EBITDA Forecast
$1.71B
2027 EBITDA Forecast
$1.75B
2028 EBITDA Forecast
$3.29B
2029 EBITDA Forecast
$2.73B
2030 EBITDA Forecast
$2.47B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ZNGA Stock Forecast Zynga Hold 14
$168.48 $12.04 -94.06%
CHNG Stock Forecast Change Healthcare Hold 11
$27.49 $0.00 -6.33%
RP Stock Forecast RealPage - 16
$0.12 $94.88 80200.00%

Genesis Healthcare Inc EBIT Forecast for 2023 - 2025 - 2030

Genesis Healthcare Inc's EBIT has seen impressive growth In the last three years, rising from $379.00M to $1.22B – a growth of 222.16%. In the next year, analysts believe that EBIT will reach $1.68B – an increase of 37.32%. For the next seven years, the forecast is for EBIT to grow by 62.96%.

2024 EBIT Forecast
$1.68B
2025 EBIT Forecast
$1.66B
2026 EBIT Forecast
$1.56B
2027 EBIT Forecast
$1.60B
2028 EBIT Forecast
$2.41B
2029 EBIT Forecast
$2.17B
2030 EBIT Forecast
$1.99B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NATI Stock Forecast National Instruments Corp Hold 18
$59.69 $48.29 -19.58%
GWRE Stock Forecast Guidewire Software Inc Outperform 2
$82.60 $79.58 -1.33%
ESTC Stock Forecast Elastic N.V. Outperform 8
$80.95 $0.00 58.74%

Genesis Healthcare Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Genesis Healthcare Inc's EPS has grown from $1.59 to $2.20 – a 38.36% increase. For the next year, 3 analysts project Genesis Healthcare Inc's EPS to drop by 6.36%, reaching $2.06. Over the next seven years, the forecast is for EPS to grow by 18.34%.

2024 EPS Forecast
$2.06
2025 EPS Forecast
$1.95
2026 EPS Forecast
$2.26
2027 EPS Forecast
$2.33
2028 EPS Forecast
$3.18
2029 EPS Forecast
$2.72
2030 EPS Forecast
$2.60
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
QLYS Stock Forecast Qualys Hold 16
$152.95 $140.27 -17.95%
ALTR Stock Forecast Altair Engineering Outperform 15
$62.83 $0.00 33.69%
NCR Stock Forecast NCR Buy 15
$27.02 $53.86 59.14%